28/02/2026
Yesterday, on the eve of the Rare Disease Awareness Day, the first webinar in the “Translating Science to Care” series, organized by the Dravet Syndrome European Federation, took place. The session, titled “How Artificial Intelligence Can Make a Difference in Dravet Syndrome”, was delivered by Julian Isla Gomez - member of the Committee for Orphan Medicinal Products at the European Medicines Agency, Data and AI Resource Manager at Microsoft, director of Foundation 29, a co-founder of our Federation and also a father of a Dravet child.
In a clear and accessible way, Julian demonstrated how technology – and AI in particular – can support the diagnosis and management of rare diseases, using as an example.
He presented innovative tools that can help patients and families how to better understand complex medical records, navigate and assess eligibility for clinical trials, facilitate communication with healthcare professionals about complex conditions or visualize medical data in a more accessible and meaningful way.
Some of these solutions are already being implemented in medical centers across Europe. By integrating and analyzing data from multiple sources, AI tools can extract, evaluate, and transform complex medical information into simple, understandable summaries or visual infographics.
This webinar highlighted the tremendous potential of technology to make medical documentation more transparent and to support families in managing appointments, monitoring medications and navigating daily life with Dravet Syndrome.
Yesterday's presentation was a powerful example of how translating science into practical tools can truly improve care. And that is even more important when dealing with a rare disease!